SFM
AGTC

Sphera Funds Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Sphera Funds Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-200,124
Closed -$3.07M – 147
2015
Q2 		$3.07M Sell
200,124
-35,000
-15% -$671K 0.3% 86
2015
Q1 		$4.7M Buy
235,124
+70,000
+42% +$1.57M 0.49% 46
2014
Q4 		$3.47M Sell
165,124
-45,600
-22% -$929K 0.59% 54
2014
Q3 		$3.92M Buy
+210,724
New +$3.82M 0.48% 50

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sphera Funds Management's AGTC Position: Q3 2015 in Review

Sphera Funds Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2015, closing a stake of 200,124 shares — an estimated $3.07M sold.

Sphera Funds Management first reported a position in AGTC in Q3 2014 and held it in 4 quarters. The position peaked at $4.7M in Q1 2015. 60 funds tracked by Wall St. Rank hold AGTC as of Q3 2015.

  • Sphera Funds Management reported no remaining Applied Genetic Technologies Corporation position as of Q3 2015 after selling out during the quarter.
  • Sphera Funds Management sold 200,124 Applied Genetic Technologies Corporation shares in Q3 2015, an estimated $3.07M.
  • Sphera Funds Management first reported a position in Applied Genetic Technologies Corporation in Q3 2014 and held it in 4 quarters.
  • Sphera Funds Management's Applied Genetic Technologies Corporation position peaked at $4.7M in Q1 2015.
  • 60 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2015.

Based on Sphera Funds Management's 13F filing for Q3 2015, filed 16 Nov 2015.